Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Medicare Bridge programme is a new nationwide initiative from the Centers for Medicare & Medicaid Services (CMS) designed to help eligible Medicare beneficiaries access FDA-approved GLP-1 medications for weight management at a predictable and more affordable US$50 monthly copay for those who qualify
An innovative injectable that helps restore lost facial volume and promote collagen production, providing a natural-looking enhancement from within
OCN, 1:1000, Millipore
The guide on water to mix with peptides explains why diluent choice matters so much
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs
US$ 21.36
US$ 21.82
US$ 25.27
